| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Growth_fac_rcpt_ | 1.29e-05 | 156 | 62 | 6 | IPR009030 | |
| Domain | - | 1.01e-04 | 73 | 62 | 4 | 2.60.120.260 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 9.42e-05 | 28 | 45 | 3 | M77 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6B HEYL PHLDB1 TIMM23B ANXA11 NAV2 CUL9 LAMC3 ARID1A CABIN1 BAHD1 | 9.26e-06 | 1105 | 68 | 11 | 35748872 |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 6327073 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10385621 | ||
| Pubmed | 1.18e-05 | 71 | 68 | 4 | 23400010 | ||
| Pubmed | 2.89e-05 | 814 | 68 | 9 | 23251661 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 29320740 | ||
| Pubmed | New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. | 5.62e-05 | 6 | 68 | 2 | 30046112 | |
| Pubmed | 8.39e-05 | 117 | 68 | 4 | 17145500 | ||
| Pubmed | 1.09e-04 | 47 | 68 | 3 | 35462405 | ||
| Pubmed | 1.12e-04 | 126 | 68 | 4 | 16284245 | ||
| Pubmed | Nav2 is necessary for cranial nerve development and blood pressure regulation. | 1.34e-04 | 9 | 68 | 2 | 20184720 | |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 1.72e-04 | 419 | 68 | 6 | 28700943 | |
| Pubmed | Novel features of boundary cap cells revealed by the analysis of newly identified molecular markers. | 2.04e-04 | 58 | 68 | 3 | 19243017 | |
| Pubmed | The expression of Sox17 identifies and regulates haemogenic endothelium. | 2.05e-04 | 11 | 68 | 2 | 23604320 | |
| Pubmed | TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. | 2.90e-04 | 13 | 68 | 2 | 16052631 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | 3.07e-04 | 164 | 68 | 4 | 22967998 | |
| Pubmed | Parathyroid hormone regulates fetal-placental mineral homeostasis. | 3.89e-04 | 15 | 68 | 2 | 19968565 | |
| Pubmed | Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. | 3.89e-04 | 15 | 68 | 2 | 14672936 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 12971992 | ||
| Pubmed | 4.36e-04 | 75 | 68 | 3 | 20637190 | ||
| Pubmed | Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac. | 4.44e-04 | 16 | 68 | 2 | 21352545 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 17273555 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 5.03e-04 | 17 | 68 | 2 | 15821257 | |
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 21082674 | ||
| Pubmed | 6.30e-04 | 19 | 68 | 2 | 15051154 | ||
| Pubmed | 7.44e-04 | 90 | 68 | 3 | 32857879 | ||
| Pubmed | 8.48e-04 | 22 | 68 | 2 | 34998785 | ||
| Pubmed | 9.24e-04 | 220 | 68 | 4 | 24705354 | ||
| Pubmed | A forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity. | 9.28e-04 | 23 | 68 | 2 | 22761313 | |
| Pubmed | 1.07e-03 | 102 | 68 | 3 | 9734811 | ||
| Pubmed | Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease. | 1.10e-03 | 25 | 68 | 2 | 26100917 | |
| Pubmed | Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring. | 1.19e-03 | 26 | 68 | 2 | 39152101 | |
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.19e-03 | 26 | 68 | 2 | 19369401 | |
| Pubmed | 1.28e-03 | 27 | 68 | 2 | 31505254 | ||
| Pubmed | 1.38e-03 | 28 | 68 | 2 | 30037996 | ||
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 1.48e-03 | 29 | 68 | 2 | 12435358 | |
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 1.58e-03 | 30 | 68 | 2 | 24552588 | |
| Pubmed | Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. | 1.69e-03 | 31 | 68 | 2 | 15583024 | |
| Pubmed | 1.91e-03 | 268 | 68 | 4 | 33640491 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 1.91e-03 | 33 | 68 | 2 | 26830346 | |
| Pubmed | 1.91e-03 | 33 | 68 | 2 | 27100196 | ||
| GeneFamily | Proteases, serine | 5.15e-04 | 63 | 45 | 3 | 738 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.12e-03 | 20 | 45 | 2 | 736 | |
| Coexpression | DCA_UP.V1_UP | 5.44e-07 | 186 | 68 | 7 | M2762 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MYOCYTES | 2.17e-05 | 129 | 68 | 5 | MM3644 | |
| Coexpression | LINDSTEDT_DENDRITIC_CELL_MATURATION_C | 2.20e-05 | 63 | 68 | 4 | M9210 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-10 | 187 | 68 | 8 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-08 | 184 | 68 | 7 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 2.24e-07 | 168 | 68 | 6 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.34e-07 | 188 | 68 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-07 | 188 | 68 | 6 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-07 | 191 | 68 | 6 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-07 | 191 | 68 | 6 | f892f725a32e704cd18fec2f6d1db82993e7e79a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 192 | 68 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.91e-07 | 192 | 68 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 192 | 68 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-07 | 192 | 68 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-07 | 194 | 68 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-07 | 194 | 68 | 6 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.54e-07 | 196 | 68 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-07 | 196 | 68 | 6 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-07 | 196 | 68 | 6 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-07 | 198 | 68 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-07 | 198 | 68 | 6 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 6.05e-07 | 199 | 68 | 6 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 3.28e-06 | 149 | 68 | 5 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.73e-06 | 167 | 68 | 5 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 6.61e-06 | 172 | 68 | 5 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 7.59e-06 | 177 | 68 | 5 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.46e-06 | 181 | 68 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.46e-06 | 181 | 68 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.46e-06 | 181 | 68 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-06 | 182 | 68 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.69e-06 | 182 | 68 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-06 | 183 | 68 | 5 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 185 | 68 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.41e-06 | 185 | 68 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.41e-06 | 185 | 68 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 186 | 68 | 5 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 186 | 68 | 5 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 186 | 68 | 5 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.91e-06 | 187 | 68 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.91e-06 | 187 | 68 | 5 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 188 | 68 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.02e-05 | 188 | 68 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 188 | 68 | 5 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.04e-05 | 189 | 68 | 5 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 189 | 68 | 5 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-05 | 189 | 68 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 190 | 68 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 190 | 68 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 190 | 68 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 190 | 68 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 190 | 68 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 191 | 68 | 5 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 191 | 68 | 5 | 44631226f59364098a7dd58058e6970a75441009 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.10e-05 | 191 | 68 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-05 | 191 | 68 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 192 | 68 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 192 | 68 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 192 | 68 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 192 | 68 | 5 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.13e-05 | 192 | 68 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-05 | 192 | 68 | 5 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 192 | 68 | 5 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-05 | 192 | 68 | 5 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 192 | 68 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 193 | 68 | 5 | 47d189bac0ef4df2f5c6dd987e46aca85bd7e2af | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 193 | 68 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 193 | 68 | 5 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 193 | 68 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 193 | 68 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-05 | 193 | 68 | 5 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-05 | 193 | 68 | 5 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-05 | 193 | 68 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.18e-05 | 194 | 68 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.18e-05 | 194 | 68 | 5 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-05 | 194 | 68 | 5 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.18e-05 | 194 | 68 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-05 | 194 | 68 | 5 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | 20a0439fa02c5f8107612e34c7ab54120b9b8573 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 194 | 68 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 194 | 68 | 5 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 194 | 68 | 5 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 194 | 68 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 195 | 68 | 5 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.21e-05 | 195 | 68 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 195 | 68 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 195 | 68 | 5 | 613bea20c3d82c22a6af4c1a668af6fcf11fec0a | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.21e-05 | 195 | 68 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 195 | 68 | 5 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| Drug | 11-R | 5.75e-08 | 35 | 67 | 5 | CID016058680 | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A | 1.89e-06 | 198 | 67 | 7 | 387_DN | |
| Drug | SureCN434017 | 8.53e-06 | 2 | 67 | 2 | CID015184871 | |
| Drug | Y-19,432 | 8.53e-06 | 2 | 67 | 2 | CID000131315 | |
| Drug | timegadine | 8.66e-06 | 14 | 67 | 3 | CID000068902 | |
| Drug | benzotriazole | 1.08e-05 | 15 | 67 | 3 | CID000007220 | |
| Drug | neamine | 1.42e-05 | 50 | 67 | 4 | CID000072392 | |
| Drug | 1-aminopyrrole | 2.55e-05 | 3 | 67 | 2 | CID000136589 | |
| Drug | sodium cromoglycate | 3.58e-05 | 63 | 67 | 4 | CID000002881 | |
| Drug | AC1NSYHD | 4.14e-05 | 23 | 67 | 3 | CID005319705 | |
| Drug | methyl orsellinate | 5.10e-05 | 4 | 67 | 2 | CID000076658 | |
| Drug | pentylhydrazine | 5.10e-05 | 4 | 67 | 2 | CID000014246 | |
| Drug | AC1NSP79 | 5.10e-05 | 4 | 67 | 2 | CID005313497 | |
| Drug | lipoxin A5 | 5.10e-05 | 4 | 67 | 2 | CID006439927 | |
| Drug | T-22083 | 5.10e-05 | 4 | 67 | 2 | CID006439700 | |
| Drug | AC1NR0V5 | 5.10e-05 | 4 | 67 | 2 | CID005282813 | |
| Drug | 13-hydroperoxylinoleic acid | 5.35e-05 | 25 | 67 | 3 | CID006438144 | |
| Drug | AC1Q6O8R | 8.48e-05 | 5 | 67 | 2 | CID000009791 | |
| Drug | 14,15-DiHETE | 8.48e-05 | 5 | 67 | 2 | CID016061119 | |
| Drug | CP 66248 | 8.48e-05 | 5 | 67 | 2 | CID000057946 | |
| Drug | WY-50295 tromethamine | 8.48e-05 | 5 | 67 | 2 | CID006918158 | |
| Drug | 14-hydroxydocosahexaenoic acid | 8.48e-05 | 5 | 67 | 2 | CID006439735 | |
| Drug | AC1L2VAC | 8.48e-05 | 5 | 67 | 2 | CID000129261 | |
| Drug | 2-hexen-1-al | 1.14e-04 | 32 | 67 | 3 | CID000010460 | |
| Drug | AC1L3XNA | 1.25e-04 | 33 | 67 | 3 | CID000123970 | |
| Drug | C0107 | 1.25e-04 | 33 | 67 | 3 | CID000018639 | |
| Drug | AC1L571W | 1.27e-04 | 6 | 67 | 2 | CID000171201 | |
| Drug | colnelenic acid | 1.27e-04 | 6 | 67 | 2 | CID006441679 | |
| Drug | isamoxole | 1.27e-04 | 6 | 67 | 2 | CID000042118 | |
| Drug | fenleuton | 1.27e-04 | 6 | 67 | 2 | CID000072059 | |
| Drug | CPHU | 1.27e-04 | 6 | 67 | 2 | CID000124471 | |
| Drug | BW A797C | 1.27e-04 | 6 | 67 | 2 | CID006439067 | |
| Drug | AC1MQ2IQ | 1.27e-04 | 6 | 67 | 2 | CID003394960 | |
| Drug | AC1O5XSP | 1.37e-04 | 34 | 67 | 3 | CID006442739 | |
| Drug | 4 BC | 1.77e-04 | 7 | 67 | 2 | CID005326934 | |
| Drug | RvD1 | 1.77e-04 | 7 | 67 | 2 | CID016061135 | |
| Drug | 12-IODE | 1.77e-04 | 7 | 67 | 2 | CID006450050 | |
| Drug | Bay 08276 | 1.77e-04 | 7 | 67 | 2 | CID000134943 | |
| Drug | RG 6866 | 1.77e-04 | 7 | 67 | 2 | CID000129232 | |
| Drug | 4-nitrophenyl carbonate | 1.77e-04 | 7 | 67 | 2 | CID000078756 | |
| Drug | metyrapone | 1.85e-04 | 179 | 67 | 5 | CID000004174 | |
| Drug | Calcort | 1.91e-04 | 38 | 67 | 3 | CID000026709 | |
| Drug | 11,14,15-THET | 2.06e-04 | 39 | 67 | 3 | CID006439531 | |
| Drug | Prifelone | 2.36e-04 | 8 | 67 | 2 | CID000071751 | |
| Drug | lonapalene | 2.36e-04 | 8 | 67 | 2 | CID000056237 | |
| Drug | colneleic acid | 2.36e-04 | 8 | 67 | 2 | CID006441681 | |
| Drug | Cgs 22745 | 2.36e-04 | 8 | 67 | 2 | CID006439321 | |
| Drug | TEI-8005 | 2.36e-04 | 8 | 67 | 2 | CID006438655 | |
| Drug | htyA | 2.36e-04 | 8 | 67 | 2 | CID000152267 | |
| Drug | CID11130648 | 2.36e-04 | 8 | 67 | 2 | CID011130648 | |
| Drug | CDNQ | 2.36e-04 | 8 | 67 | 2 | CID000126468 | |
| Drug | CBS-113 A | 2.36e-04 | 8 | 67 | 2 | CID000163834 | |
| Drug | S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2R)-2-[4-(2-methylpropyl)phenyl]propanethioate | 2.40e-04 | 41 | 67 | 3 | CID009854504 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 2.58e-04 | 42 | 67 | 3 | CID006439610 | |
| Drug | BAY X 1005 | 2.76e-04 | 43 | 67 | 3 | CID000123723 | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 4548_UP | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 2306_UP | |
| Drug | AC1Q6O8T | 2.88e-04 | 197 | 67 | 5 | CID000002193 | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 5317_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 1473_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; PC3; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 5787_UP | |
| Drug | rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 6192_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 3223_UP | |
| Drug | HA-1077 dihydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.02e-04 | 199 | 67 | 5 | 343_DN | |
| Drug | 14,15-leukotriene A4 | 3.03e-04 | 9 | 67 | 2 | CID006439604 | |
| Drug | octadeca-9,12-dien-1-ol | 3.03e-04 | 9 | 67 | 2 | CID000068168 | |
| Drug | U-56467 | 3.03e-04 | 9 | 67 | 2 | CID006439532 | |
| Drug | 8,15-diHPETE | 3.03e-04 | 9 | 67 | 2 | CID005283181 | |
| Drug | T 0757 | 3.03e-04 | 9 | 67 | 2 | CID006439291 | |
| Drug | 13-hydroxylinoleic acid | 3.03e-04 | 9 | 67 | 2 | CID006438633 | |
| Drug | AC1NSXHC | 3.03e-04 | 9 | 67 | 2 | CID005371969 | |
| Drug | U-66,855 | 3.03e-04 | 9 | 67 | 2 | CID000127235 | |
| Drug | ODYA | 3.03e-04 | 9 | 67 | 2 | CID000001931 | |
| Drug | 11-dehydrotetrahydrocorticosterone | 3.03e-04 | 9 | 67 | 2 | CID000011272 | |
| Drug | diolone | 3.03e-04 | 9 | 67 | 2 | CID000101774 | |
| Drug | A-78773 | 3.03e-04 | 9 | 67 | 2 | CID000071460 | |
| Drug | S 19812 | 3.03e-04 | 9 | 67 | 2 | CID005744460 | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.09e-04 | 200 | 67 | 5 | 2633_UP | |
| Disease | Malignant neoplasm of breast | HOXA3 BOC HEYL COL19A1 CYP19A1 TICAM1 CUBN ARID1A DNAH9 NOTCH4 | 1.14e-04 | 1074 | 65 | 10 | C0006142 |
| Disease | late-onset myasthenia gravis | 7.15e-04 | 18 | 65 | 2 | EFO_1001490 | |
| Disease | carpal tunnel syndrome | 1.01e-03 | 89 | 65 | 3 | EFO_0004143 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.74e-03 | 28 | 65 | 2 | DOID:3717 (is_marker_for) | |
| Disease | osteoarthritis (is_implicated_in) | 1.74e-03 | 28 | 65 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | osteoporosis (is_implicated_in) | 2.13e-03 | 31 | 65 | 2 | DOID:11476 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGVLMGGRYTPPDCT | 126 | O60909 | |
| GGANMPNLYPGAPGA | 66 | P50995 | |
| YNGMCLQGPAGVPGR | 51 | Q96CG8 | |
| MAGLSLPSGGPVLPY | 66 | B1ANY3 | |
| VGPLPGPCYMRALSP | 116 | P19801 | |
| TVGSPAGDMPYPCLG | 216 | P80365 | |
| NPSPAYGGRLCLGPM | 581 | Q8WXS8 | |
| FCAPGPPGRSMLAAL | 296 | Q8IY67 | |
| CFVVPAGPRMSGAPG | 451 | Q86UR1 | |
| GPDYRLMNGGTPIPN | 136 | Q2T9L4 | |
| VLPPSFPYGGMENPC | 261 | P09960 | |
| PGLGNVAMGPRQHYP | 1266 | O14497 | |
| MVCPNGYDPGGRHLL | 1 | Q9UN72 | |
| LPGDLYPGGARNPMA | 11 | Q9HB89 | |
| RSPVPPGAGGYLNSM | 266 | O43365 | |
| NPAICRYPLGMSGGQ | 26 | Q16832 | |
| CPRGYRMQGPSLPCL | 4741 | Q8NDA2 | |
| VAPCPAGLPRGYMTP | 1386 | Q9UPA5 | |
| AGLPRGYMTPASPAG | 1391 | Q9UPA5 | |
| PPGLGPSMLSHNSCY | 1356 | Q9UBG0 | |
| SSPGPAGRPAGAMLY | 301 | Q9NQ87 | |
| MPGYLGCFVDSGAPP | 121 | Q8NCW0 | |
| GPCSPYQFRLMGPGK | 471 | O60774 | |
| ATCYGSGGRMEGPPP | 216 | Q969W9 | |
| QILPGMLCAGYPEGR | 221 | Q5K4E3 | |
| QMGRYCGVDLPPPGS | 1346 | O60494 | |
| LDIMTYRLGPGSPPG | 131 | Q8N0W3 | |
| CPYTMVPLGGLPGHQ | 901 | Q9BWV1 | |
| CPAGMVNGRFGPDFP | 571 | Q9Y6J0 | |
| SIPGPGYCMGIGPLI | 46 | P11511 | |
| AMLAAQAYGRPGPPG | 1046 | Q14993 | |
| YILPPSMGTQPGCGL | 201 | Q8TDV2 | |
| YPQGTHLLLGMGCNP | 236 | Q9NQT6 | |
| PMPGNPADYNGLCVG | 356 | Q8TBE0 | |
| GGYSPCPMLPEGKLS | 391 | Q8TBE0 | |
| YAAPEPMGPCRGQAD | 1951 | Q8IWT3 | |
| LAPGFPLPGNMDYNG | 4146 | Q9NYC9 | |
| QVGPYPGLPMPLGLC | 136 | Q8IXS0 | |
| PLSEGPHSLGCYNPM | 741 | P20273 | |
| GCLPLLAPPGGTSMF | 156 | P0C7X4 | |
| GPGLRPSTMLCAGYL | 261 | P0CW18 | |
| EGYRLPAPMGCPASL | 891 | Q9UF33 | |
| PQGCRLFYGDLGPMP | 246 | O14896 | |
| AAPMTLLYQSPGCGP | 311 | O15296 | |
| MPGPSSGQACSRPAY | 1001 | Q9P2F6 | |
| PRGMVPLGPQNYGGA | 181 | P81877 | |
| PLGPQNYGGAMRPPL | 186 | P81877 | |
| YPGPGGSILQPDMLC | 196 | Q9NRR2 | |
| MPAPLGYVPGLGRGA | 11 | O94906 | |
| IGPGGNMPGYLRPET | 286 | P41250 | |
| MLLYRGAPAGPGAPG | 1 | Q8TE76 | |
| QAGDAPSMGNGYPPR | 816 | Q8IVL1 | |
| PPGMFTCLAGFIEPG | 346 | Q9BQG2 | |
| MPSLLGAPPYSGLGG | 236 | Q8TC41 | |
| LGLGMPCGVYTPRCG | 61 | P22692 | |
| GGCGALPQAAMLTPP | 1556 | Q99466 | |
| CNNPEPKYGGMPCLG | 811 | Q13591 | |
| PKYGGMPCLGPSLEY | 816 | Q13591 | |
| PRPRPGCCAAPGMQY | 371 | Q9H3T3 | |
| YCLLHPNGPMLGPQA | 436 | Q5GH72 | |
| GKRCPGPNTYNILPG | 226 | Q8N7X2 | |
| APYGARMPFGGQVPL | 601 | Q8IUC6 | |
| GPGYMASVGQGCPLP | 391 | Q5VX71 | |
| CGYQPPGAPPGLGSM | 131 | Q8N5L8 | |
| GICPYLMPGVGVPLR | 156 | Q9C0B7 | |
| LAGVPLTGMNPLCPY | 31 | Q5SRD1 | |
| PLSPMANGGRYLLSP | 221 | Q86UU1 | |
| MAPAPVPALGTLGCY | 1 | Q5PR19 | |
| AGSALDPSYGPLLMP | 251 | A8MV65 | |
| LHAYRMCRPGQPPGS | 311 | Q6ZT98 | |
| RGPLPQCAYGMGLPP | 466 | Q9Y6Q6 | |
| SCAPGYKREMPQGGP | 686 | Q9Y6N6 | |
| YCAVPPRGPLGQGAM | 291 | Q96NK8 |